Table 4.
Observations | Group-I (Mean ± SD) | Group-II (Mean ± SD) | p Values | Percentage Difference (%) |
---|---|---|---|---|
Fasting blood glucose level (mg/dL) | 113.25 ± 5.58 | 142.85 ± 6.26 * | 0.001 | 23.12 |
HbA1c (%) | 5.55 ± 0.26 | 6.61 ± 0.20 * | 0.001 | 17.43 |
PI | 0.86 ± 0.19 | 0.92 ± 0.39 * | 0.05 | 6.74 |
GI | 0.85 ± 0.25 | 1.10 ± 0.36 * | 0.04 | 25.64 |
PPD (mm) | 2.13 ± 0.27 | 2.42 ± 0.65 * | 0.05 | 12.75 |
CAL (mm) | 2.65 ± 0.59 | 2.60 ± 0.72 * | 0.05 | 1.90 |
IL-17 (pg/mL) | 0.16 ± 0.02 | 0.16 ± 0.03 | 0.99 | 6.45 |
* p < 0.05 significant compared between the group-I with group-II after treatment.